Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 13, 2021

BUY
$259.0 - $414.71 $1,036 - $1,658
4 New
4 $1,000
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $3,971 - $4,585
-15 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$219.29 - $241.72 $3,289 - $3,625
15 New
15 $4,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track First National Bank Of South Miami Portfolio

Follow First National Bank Of South Miami and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank Of South Miami, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank Of South Miami with notifications on news.